OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanomedicines for hepatocellular carcinoma therapy: Challenges and clinical applications
Mahsa Sedighi, Zahra Mahmoudi, Samin Abbaszadeh, et al.
Materials Today Communications (2023) Vol. 34, pp. 105242-105242
Open Access | Times Cited: 14
Mahsa Sedighi, Zahra Mahmoudi, Samin Abbaszadeh, et al.
Materials Today Communications (2023) Vol. 34, pp. 105242-105242
Open Access | Times Cited: 14
Showing 14 citing articles:
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Development and evaluation of hyaluronic acid-coated chitosan nanoparticles for improved delivery of sorafenib tosylate in the treatment of hepatocellular carcinoma
Putrevu Sreelaya, Sankha Bhattacharya, Darshan Bhirud, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access | Times Cited: 2
Putrevu Sreelaya, Sankha Bhattacharya, Darshan Bhirud, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access | Times Cited: 2
HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma
Chen Shen, Mei Li, Yujuan Duan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Chen Shen, Mei Li, Yujuan Duan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy
Xiaqing Zhou, Yaping Li, Shuangsuo Dang
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 164-176
Open Access | Times Cited: 5
Xiaqing Zhou, Yaping Li, Shuangsuo Dang
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 164-176
Open Access | Times Cited: 5
Anti-liver cancer effects and mechanisms and its application in nano DDS of polysaccharides: A review
Yan Zheng, Hanqing Chen
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135181-135181
Closed Access | Times Cited: 4
Yan Zheng, Hanqing Chen
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135181-135181
Closed Access | Times Cited: 4
A Dual‐Targeting Biomimetic Nanoplatform Integrates SDT/CDT/Gas Therapy to Boost Synergistic Ferroptosis for Orthotopic Hepatocellular Carcinoma Therapy
Wen Meng, Ting Chen, Xueping Li, et al.
Advanced Science (2025)
Open Access
Wen Meng, Ting Chen, Xueping Li, et al.
Advanced Science (2025)
Open Access
Unveiling the potency of ZnO and CuO nanocomposites in combating hepatocellular carcinoma by inducing cell death and suppressing migration
Rasha Mahmoud Allam, Nesma M. E. Abo El-Nasr, Marawan A. Elbaset, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Rasha Mahmoud Allam, Nesma M. E. Abo El-Nasr, Marawan A. Elbaset, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Targeted Drug Delivery: Principles and Strategies
Meemansha Sharma, Mamta Meena, Ayushi Vaidhya, et al.
Methods in pharmacology and toxicology (2025), pp. 53-69
Closed Access
Meemansha Sharma, Mamta Meena, Ayushi Vaidhya, et al.
Methods in pharmacology and toxicology (2025), pp. 53-69
Closed Access
Design and Characterization of Glypican-3 Targeted Liposomes with Cantharidin Encapsulation for Hepatocellular Carcinoma Treatment
Xue Zhang, Chen Jiang, Yin Yuan, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105934-105934
Closed Access | Times Cited: 2
Xue Zhang, Chen Jiang, Yin Yuan, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105934-105934
Closed Access | Times Cited: 2
Dependence of diamond nanoparticle cytotoxicity on physicochemical parameters: comparative studies of glioblastoma, breast cancer, and hepatocellular carcinoma cell lines
Barbara Wójcik, Katarzyna Zawadzka, Sławomir Jaworski, et al.
Nanotoxicology (2023) Vol. 17, Iss. 4, pp. 310-337
Closed Access | Times Cited: 5
Barbara Wójcik, Katarzyna Zawadzka, Sławomir Jaworski, et al.
Nanotoxicology (2023) Vol. 17, Iss. 4, pp. 310-337
Closed Access | Times Cited: 5
Development of a decellularized liver matrix-based nanocarrier for liver regeneration after partial hepatectomy
Yu‐Chuan Chiu, Kai‐Wen Huang, Yong‐Heng Lin, et al.
Journal of Materials Science (2023) Vol. 58, Iss. 38, pp. 15162-15180
Closed Access | Times Cited: 4
Yu‐Chuan Chiu, Kai‐Wen Huang, Yong‐Heng Lin, et al.
Journal of Materials Science (2023) Vol. 58, Iss. 38, pp. 15162-15180
Closed Access | Times Cited: 4
Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Reza Yazdani, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Reza Yazdani, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment
Sumit Roy, Vancha Harish, Sharfuddin Mohd, et al.
Advanced Therapeutics (2024)
Closed Access
Sumit Roy, Vancha Harish, Sharfuddin Mohd, et al.
Advanced Therapeutics (2024)
Closed Access
Stimuli-responsive carrageenan-based biomaterials for biomedical applications
Alireza Ghasempour, Mohammad Reza Naderi Allaf, Kianush Charoghdoozi, et al.
International Journal of Biological Macromolecules (2024), pp. 138920-138920
Closed Access
Alireza Ghasempour, Mohammad Reza Naderi Allaf, Kianush Charoghdoozi, et al.
International Journal of Biological Macromolecules (2024), pp. 138920-138920
Closed Access
An update on the therapeutic role of RNAi in NAFLD/NASH
Hamideh Dehghan, Alireza Ghasempour, Mahboobeh Sabeti akbar-abad, et al.
Progress in molecular biology and translational science (2023), pp. 45-67
Closed Access
Hamideh Dehghan, Alireza Ghasempour, Mahboobeh Sabeti akbar-abad, et al.
Progress in molecular biology and translational science (2023), pp. 45-67
Closed Access
